Biopharma

Low-to-Moderate Agreement Seen for Diagnosing Breast Cancer-Related Lymphedema

Low-to-Moderate Agreement Seen for Diagnosing Breast Ca...

Apr 24, 2025 0

THURSDAY, April 24, 2025 -- Different measurement tools and diagnostic criteria...

School-Based Asthma Therapy Boosts Asthma Control, Cuts Acute Health Care Use

School-Based Asthma Therapy Boosts Asthma Control, Cuts...

Apr 24, 2025 0

THURSDAY, April 24, 2025 -- School-based asthma therapy (SBAT) can help improve...

Single-Dose Baloxavir Treatment Can Reduce Influenza Transmission

Single-Dose Baloxavir Treatment Can Reduce Influenza Tr...

Apr 24, 2025 0

THURSDAY, April 24, 2025 -- A single-dose baloxavir treatment can reduce influe...

Cold Hypersensitivity, Heavy Leg Sensation Tied to Risk for Varicose Veins

Cold Hypersensitivity, Heavy Leg Sensation Tied to Risk...

Apr 24, 2025 0

THURSDAY, April 24, 2025 -- Cold hypersensitivity and a feeling of heaviness in...

Brensocatib Leads to Lower Rate of Pulmonary Exacerbations in Bronchiectasis

Brensocatib Leads to Lower Rate of Pulmonary Exacerbati...

Apr 24, 2025 0

THURSDAY, April 24, 2025 -- For patients with bronchiectasis, brensocatib leads...

Melphalan/Hepatic Delivery System Beneficial for Metastatic Uveal Melanoma

Melphalan/Hepatic Delivery System Beneficial for Metast...

Apr 24, 2025 0

THURSDAY, April 24, 2025 -- For patients with unresectable metastatic uveal mel...

Metabolic Syndrome Linked to Increased Risk for Young-Onset Dementia

Metabolic Syndrome Linked to Increased Risk for Young-O...

Apr 24, 2025 0

THURSDAY, April 24, 2025 -- Metabolic syndrome (MetS) and its individual compon...

Prevalence of Most Cancer Risk Factors Unchanged Before, After Pandemic

Prevalence of Most Cancer Risk Factors Unchanged Before...

Apr 24, 2025 0

THURSDAY, April 24, 2025 -- Smoking rates continued to decline during the COVID...

Boston Scientific plans to make ground despite $200M in tariff headwinds

Boston Scientific plans to make ground despite $200M in...

Apr 24, 2025 0

Boston Scientific believes it can absorb the hit based on the continuing growth ...

Bristol Myers says schizophrenia drug launch ‘off to a solid start’

Bristol Myers says schizophrenia drug launch ‘off to a ...

Apr 24, 2025 0

Net sales of Cobenfy, whose success is imperative for Bristol Myers, totaled $27...

Merck ‘willing to work’ with Trump administration on price gap between US, international medicines

Merck ‘willing to work’ with Trump administration on pr...

Apr 24, 2025 0

The company's CEO, Rob Davis, is joining his industry peers in pushing for great...

BMS shrugs off Cobenfy's schizophrenia hit as it gears up for Alzheimer's psychosis readout, 7 trial starts

BMS shrugs off Cobenfy's schizophrenia hit as it gears ...

Apr 24, 2025 0

Bristol Myers Squibb remains confident that Cobenfy can come out ahead of its re...

Sanofi stays on course amid tariff turmoil

Sanofi stays on course amid tariff turmoil

Apr 24, 2025 0

The company reiterated its financial outlook for the year but is struggling to p...

Lowering blood pressure reduces dementia risk in patients with hypertension, large China trial reveals

Lowering blood pressure reduces dementia risk in patien...

Apr 24, 2025 0

A study of almost 34,000 people in rural China has revealed that lowering blood ...

Merck takes $200M tariff hit, trimming its gross profits

Merck takes $200M tariff hit, trimming its gross profits

Apr 24, 2025 0

The drugmaker absorbed additional tariff-related costs in the first quarter, but...

Sanofi stays course amid tariff turmoil

Sanofi stays course amid tariff turmoil

Apr 24, 2025 0

The company reiterated its financial outlook for the year but is struggling to p...

Sanofi and Regeneron's high-flying Dupixent on course for an 'inflection year' in COPD

Sanofi and Regeneron's high-flying Dupixent on course f...

Apr 24, 2025 0

Sanofi is on a “record-setting pace,” as it relates to Medicare and commercial c...

Opinion: The U.S. needs an alternative organization to protect vaccine guidance from political interference

Opinion: The U.S. needs an alternative organization to ...

Apr 24, 2025 0

A former FDA commissioner and a former Institute of Medicine president are teami...

Public health leaders, distrustful of RFK Jr., stand up project to defend vaccines

Public health leaders, distrustful of RFK Jr., stand up...

Apr 24, 2025 0

Some key public health figures are taking an extraordinary step to try to shore ...

Roche moves to mitigate US tariff impact amid discussions with global governments

Roche moves to mitigate US tariff impact amid discussio...

Apr 24, 2025 0

Roche is working to mitigate potential impacts from tariffs by moving production...

STAT+: Harvard Medical School was already in the red. Then came Trump

STAT+: Harvard Medical School was already in the red. T...

Apr 24, 2025 0

Harvard Medical School's finances are in a precarious place as it prepares for i...

STAT+: Prestigious journal gets U.S. attorney letter, Trump’s HIV cuts slammed

STAT+: Prestigious journal gets U.S. attorney letter, T...

Apr 24, 2025 0

This is the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about ...

Human medicines European public assessment report (EPAR): Cancidas (previously Caspofungin MSD), caspofungin, Date of authorisation: 23/10/2001, Revision: 34, Status: Authorised

Human medicines European public assessment report (EPAR...

Apr 24, 2025 0

Human medicines European public assessment report (EPAR): Cancidas (previously C...

Human medicines European public assessment report (EPAR): Prevenar 13, pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed), Date of authorisation: 09/12/2009, Revision: 49, Status: Authorised

Human medicines European public assessment report (EPAR...

Apr 24, 2025 0

Human medicines European public assessment report (EPAR): Prevenar 13, pneumococ...

1
2
3
4

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.